Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Platanus is a global evergreen investment fund specializing in venture capital for innovative biotechnology and healthcare startups. The firm invests across therapeutic modalities and indications with transformative potential. Representative investments include Ray Therapeutics (optogenetics for blinding eye disease), Perfuse Therapeutics, Semma Therapeutics (acquired by Vertex Pharmaceuticals), Akouos (acquired by Eli Lilly), Korro Bio, Inipharm, Callio Therapeutics (multi-payload ADCs for cancer), and Nuvig (protein therapeutics for autoimmune disease).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Platanus.